Getagraph.com logo
NASDAQ Composite: ( -0.07%) 16 686
S&P 500 Futures
(0.10%) 5 332.50 points
Dow Jones Futures
(0.02%) 40 146 points
Nasdaq Futures
(0.17%) 18 668 points
Oil
(0.10%) $80.14
Gas
(0.61%) $2.64
Gold
(1.13%) $2 444.70
Silver
(2.90%) $32.17
Platinum
(0.21%) $1 092.30
USD/EUR
(-0.01%) $0.920
USD/NOK
(-0.04%) $10.67
USD/GBP
(0.05%) $0.787
USD/RUB
(-0.28%) $90.72

Realtime updates for Agios Pharmaceuticals Inc [AGIO]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
BUY
100.00%
return 4.44%
SELL
80.00%
return -3.23%
Last Updated17 May 2024 @ 16:00
25% discount on Stockinvest.us - Use code: Podcast

-1.89% $ 34.34

BUY 137617 min ago

@ $25.84

Issued: 14 Feb 2024 @ 13:56

Return: 32.89%

Previous signal: Feb 14 - 09:30

Previous signal: Sell

Return: 1.31 %

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 16:00):
Profile picture for Agios Pharmaceuticals Inc

Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology...

Stats
Today's Volume 654 883
Average Volume 740 677
Market Cap 1.95B
EPS $0 ( 2024-05-02 )
Next earnings date ( $-1.590 ) 2024-08-01
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -5.44
ATR14 $0.0340 (0.10%)
Insider Trading
Date Person Action Amount type
2024-04-08 Fouse Jacqualyn A Buy 15 934 Common stock
2024-04-10 Fouse Jacqualyn A Sell 7 791 Common stock
2024-04-08 Fouse Jacqualyn A Sell 15 934 Restricted stock units
2024-03-07 Foster-cheek Kaye I Sell 1 285 Common stock
2024-03-05 Foster-cheek Kaye I Sell 300 Common stock
INSIDER POWER
25.01
Last 100 transactions
Buy: 882 792 | Sell: 538 174

Volume Correlation

Long: 0.38 (neutral)
Short: -0.08 (neutral)
Signal:(58.14) Neutral

Agios Pharmaceuticals Inc Correlation

10 Most Positive Correlations
TXRH0.917
MACK0.914
PMGM0.907
IBKR0.906
ADSE0.9
CSWI0.894
CRTO0.893
SERA0.887
COOP0.886
APXI0.885
10 Most Negative Correlations
HMNF-0.937
VREX-0.931
CCRN-0.924
FORR-0.924
QDEL-0.922
GPRO-0.917
IMKTA-0.915
REKR-0.906
CYAN-0.905
PETS-0.903

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Agios Pharmaceuticals Inc Correlation - Currency/Commodity

The country flag 0.21
( neutral )
The country flag 0.16
( neutral )
The country flag 0.00
( neutral )
The country flag 0.30
( neutral )
The country flag 0.54
( weak )
The country flag 0.16
( neutral )

Agios Pharmaceuticals Inc Financials

Annual 2023
Revenue: $26.82M
Gross Profit: $17.32M (64.57 %)
EPS: $-6.33
FY 2023
Revenue: $26.82M
Gross Profit: $17.32M (64.57 %)
EPS: $-6.33
FY 2022
Revenue: $14.24M
Gross Profit: $12.54M (88.03 %)
EPS: $-1.360
FY 2021
Revenue: $0.00
Gross Profit: $0.00 (0.00 %)
EPS: $26.55

Financial Reports:

No articles found.

Agios Pharmaceuticals Inc Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Agios Pharmaceuticals Inc

Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators